Skeletal muscle is the body’s largest organ, making up roughly 40 percent of total body mass, and its quality is now understood to be a barometer of systemic metabolic health. As people age or become physically deconditioned, fat gradually replaces muscle tissue, accumulating both between muscle fibers as adipocytes and inside the fibers themselves as lipid droplets. Using sensitive magnetic resonance imaging, the researchers quantified this fat in four regions of the thigh and followed participants for years. The results were stark: infiltration in every thigh region showed a dose-dependent relationship with all-cause mortality and with the incidence of diseases spanning cancers, cardiovascular disease, digestive, respiratory, endocrine, neurological, psychiatric, musculoskeletal, genitourinary, eye, ear, and skin conditions. Notably, the link persisted even after adjusting for body mass index, showing that TMFI captures a health risk that conventional weight measures miss entirely.

The magnitude of the effect is striking. Individuals in the highest quarter of thigh muscle fat lost more years of life after age 40 than those in the lowest quarter, and people who developed diseases at younger ages carried significantly more intramuscular fat than those who fell ill later or remained disease-free. The associations were also age- and sex-dependent, appearing more pronounced in men and in adults under 60. According to the authors, this suggests that muscle quality may be an early warning system—flagging vulnerability years or even decades before a diagnosis is ever made.

Perhaps the most consequential finding involves lifestyle. The team showed that the relationship between unhealthy habits and poor outcomes runs, in substantial part, through the muscle itself. Physical inactivity, poor diet quality, obesity, smoking, alcohol consumption, and abnormal sleep duration were each linked to higher TMFI, and mediation analyses revealed that TMFI statistically transmits the effects of these lifestyle factors onto mortality and disease incidence. Sleep followed a U-shaped curve, with the lowest muscle fat observed at roughly 7.5 hours per night, while physical activity and body weight showed nonlinear thresholds. In practical terms, keeping thigh muscle free of fat may be one of the central mechanisms by which healthy living protects the body.

To understand why some people accumulate more intramuscular fat than others, the researchers turned to genetics. In a genome-wide association study of more than 46,000 individuals of European ancestry, they identified 79 lead genetic variants across 47 loci—the majority never before connected to muscle fat. Mapping analyses converged on dozens of genes enriched for traits involving body size, fat distribution, and inflammatory diseases, with strong expression in skeletal muscle, visceral omentum adipose tissue, and reproductive organs. Several newly implicated genes are biologically compelling: ATG7, a core autophagy gene known to govern lipid droplet metabolism, and XYLB, which activates carbohydrate-driven lipogenic pathways, suggest that fat infiltration arises from fundamental disruptions in how muscle handles energy.

Genetic risk proved clinically meaningful in its own right. A polygenic risk score built from the GWAS predicted elevated all-cause mortality and nearly every major category of disease in an independent cohort of over 362,000 people. Critically, genetics and lifestyle interacted: the damaging effect of unhealthy habits was amplified in individuals with high genetic susceptibility, with both multiplicative and additive interaction patterns. The message is that people genetically prone to fatty muscle have the most to gain from exercise, diet, and sleep interventions—and the most to lose from neglecting them.

Drilling down to the cellular level, the team integrated their genetic data with single-cell transcriptomes from nearly 34,000 cells of the vastus lateralis, the largest quadriceps muscle. Among six major cell types, only myogenic cells showed significant genetic relevance to TMFI, and within this lineage, classic slow-twitch myofibers scored highest, followed by fast-twitch myofibers and unusual slow-twitch fibers carrying endothelial molecular features. This cellular picture aligns with muscle physiology: slow-twitch fibers burn fat oxidatively, and their loss—or a shift toward less oxidative fast fibers—reduces lipid clearance, permitting fat to accumulate. Damage to myofibers can also coax resident fibro/adipogenic progenitors into becoming adipocytes, seeding fat deposits within the tissue.

Multi-tissue analyses of gene expression added another layer. By combining GTEx expression quantitative trait loci with the TMFI genetic data through Mendelian randomization and transcriptome-wide association approaches, the researchers pinpointed genes whose activity in nine different tissues was consistently tied to muscle fat. Four genes—SPATA20, PWP2, RPA2, and ZNF100—showed directionally consistent associations across every tissue examined, hinting at fundamental cellular processes such as ribosome assembly, DNA replication, and transcriptional regulation as unexpected contributors to muscle composition.

The blood told an equally rich story. Of 2,923 circulating proteins measured with the Olink platform, 977 were significantly associated with TMFI, and 211 of 251 metabolites measured by nuclear magnetic resonance showed associations. Fat-related proteins such as leptin and FABP4 rose with infiltration, while protective factors like NTRK3, which promotes lipolysis and blocks adipocyte precursor differentiation, fell. Metabolically, lower cholesterol ester content within very large HDL particles signaled impaired lipid transport, and GlycA—a systemic inflammation marker—was strongly elevated. Tissue mapping traced the strongest protein signals to immune tissues, liver, and brain, painting TMFI as a whole-body phenomenon in which inflammation, hepatic fat, and even central nervous system health feed into muscle deterioration.

The team then harnessed deep learning, training one-dimensional convolutional neural networks to predict TMFI from protein or metabolite profiles alone. The proteomic signature achieved a test-set correlation of 0.71 with measured muscle fat—a remarkable result implying that a simple blood draw could one day estimate a person’s muscle fat burden without an MRI. Both blood-derived signatures predicted mortality and systemic disease incidence in independent cohorts of hundreds of thousands of participants, confirming that circulating molecules genuinely capture the biology of fat-infiltrated muscle and its consequences.

The genetic work also surfaced therapeutic leads. Searching the Drug-Gene Interaction Database, the team found that 58 TMFI-linked genes are targeted by 901 drugs, with 15 compounds hitting at least three genes. Among them are vasodilators such as dipyridamole and pentoxifylline, which improve microcirculation and have documented muscle-protective effects, and methylene blue, known to enhance mitochondrial function. More sobering, several common chemotherapy agents—cisplatin, paclitaxel, doxorubicin, and others—appear as potential promoters of muscle fat, consistent with reports that these drugs reduce muscle mass and increase intramuscular fat in cancer patients, a population in which TMFI is already linked to worse prognosis.

The authors caution that the cohort was largely European, middle-aged, and healthier than average, that TMFI was measured at a single time point, and that the study establishes associations rather than proving causation. Still, the breadth of the analysis—spanning epidemiology, genomics, single-cell biology, proteomics, metabolomics, and machine learning—makes this the first systematic portrait of what fat inside thigh muscle means for human health. If future studies confirm these mechanisms, the humble thigh scan could become a routine clinical tool, and preserving lean, fat-free muscle could take its place alongside blood pressure and cholesterol as a cornerstone of preventive medicine.

Subject of Research: Thigh muscle fat infiltration and its multi-omics determinants and health consequences

Article Title: Integrative Analysis Uncover the Effects and Multi‐Omics Features of Thigh Muscle Fat Infiltration

Article References: Integrative Analysis Uncover the Effects and Multi‐Omics Features of Thigh Muscle Fat Infiltration. (n.d.). https://doi.org/10.1111/acel.70690

Image Credits: AI Generated

DOI: 10.1111/acel.70690

Keywords: thigh muscle fat infiltration, UK Biobank, skeletal muscle quality, all-cause mortality, genome-wide association study, polygenic risk score, proteomics, metabolomics, single-cell transcriptomics, magnetic resonance imaging, lifestyle factors, aging

The new LE8 score, introduced by the American Heart Association, refines previous cardiovascular health assessment algorithms by encompassing eight critical health behaviors and factors. This study set out to quantify the association between cardiovascular health levels as measured by the LE8 score and mortality risks, providing a nuanced understanding of survival outcomes in both cancer-affected populations and those cancer-free. Researchers meticulously applied Cox proportional hazards regression models and utilized restricted cubic spline analyses to dissect these relationships with statistical precision.

Among the 29,352 adults studied, only a minority—14.8%—achieved a high LE8 cardiovascular health score, whereas 20.3% registered low scores indicative of suboptimal cardiovascular wellness. This distribution highlights a widespread public health challenge and underscores the importance of cardiovascular health maintenance. The stratification of LE8 scores into low, moderate, and high categories enabled a clear demonstration of how cardiovascular health correlates with mortality risk gradients.

For adults without cancer, the calculated hazard ratios (HRs) delineated a protective effect associated with improved LE8 scores. Specifically, individuals with moderate LE8 scores exhibited a 29% reduction in all-cause mortality risk compared to those with low scores, while those with high scores experienced an astounding 54% reduction. These findings underscore the LE8 score’s robustness as a prognostic tool and its potential utility in primary prevention strategies targeting cardiovascular events and overall survival enhancement.

When focusing on cardiovascular disease (CVD) mortality, the protective association strengthened further. Moderate LE8 scores correlated with a 42% risk reduction, and high scores nearly tripled the survival advantage with a 70% reduction in CVD mortality. This emphasizes the comprehensive cardiovascular protective effect embedded within the composite LE8 metric and validates its construction encompassing multiple modifiable health-related behaviors and biological parameters.

Intriguingly, when the population was stratified to reflect adults with cancer diagnosis histories, the LE8 score continued to demonstrate a protective trend against all-cause mortality, albeit with slightly attenuated effect sizes. Here, moderate cardiovascular health scores were associated with a 27% reduced risk of death, a significant finding affirming that optimal cardiovascular health remains critically relevant even among individuals grappling with oncologic disease. However, high LE8 scores in cancer patients did not exhibit statistically significant mortality risk reductions as clearly, indicating complex interplay between cancer pathology and cardiovascular health factors.

A noteworthy aspect of this study was the consistent protective effects observed across all eight components of the LE8 score in relation to cardiovascular mortality. This finding confirms the integrated nature of cardiovascular health determinants and advocates for multipronged interventions rather than singular focus on isolated risk factors. Each LE8 element—from diet and physical activity to blood pressure, cholesterol, glucose levels, body mass index, smoking status, and sleep health—played a vital role in enhancing cardiovascular prognosis.

The methodological approach using Cox regression modeling allowed adjustment for critical confounders, strengthening the causal inferences drawn from the associations observed. The use of restricted cubic splines further permitted the exploration of potential nonlinear relationships between LE8 score levels and mortality risks, enhancing understanding beyond binary risk categorizations and revealing dose-response dynamics.

Crucially, this study bridges a knowledge gap concerning the interplay between cardiovascular health and cancer survivorship, an increasingly pertinent arena given the rising numbers of aging cancer survivors prone to cardiovascular complications. The data advocate for integrating cardiovascular health optimization as an essential aspect of comprehensive cancer care and survivorship programs to improve longevity outcomes.

Moreover, the public health implications are profound. Given the prevalence of suboptimal cardiovascular health in the general population and the mounting burden of cancer diagnoses, strategies to improve LE8 scores at the population level could translate into reduced overall mortality and better quality of life. Health policy initiatives could prioritize cardiovascular health screening using the LE8 algorithm, lifestyle modification programs, and targeted therapeutics integration across diverse clinical settings.

This pioneering research dovetails with ongoing efforts to enhance predictive algorithms incorporating lifestyle, biological, and clinical factors to generate personalized mortality risk profiles. It reinforces the importance of holistic health metrics that capture multiple dimensions of well-being beyond traditional singular biomarker assessments, advancing precision medicine paradigms.

In conclusion, the 2025 study led by Peng et al. provides robust epidemiological evidence that the Life’s Essential 8 cardiovascular health score is a powerful tool for predicting both cardiovascular and all-cause mortality risks in adults, regardless of cancer status. These findings serve as a clarion call for clinicians, researchers, and public health authorities to embrace the LE8 paradigm to foster healthier populations and mitigate deaths linked to cardiovascular disease and potentially cancer-associated mortality.

Continued longitudinal research and intervention trials are warranted to explore causality more definitively and assess how modifications in LE8 components may translate into mortality improvements over time, particularly in vulnerable groups such as cancer survivors. As the medical community progresses toward integrated chronic disease prevention and management, the Life’s Essential 8 stands out as a beacon guiding evidence-based cardiovascular health promotion.

Subject of Research:
Cardiovascular health assessment using the American Heart Association’s Life’s Essential 8 (LE8) and its association with all-cause and cardiovascular mortality in adults with and without cancer.

Article Title:
Association of the American Heart Association’s new “Life’s Essential 8″ cardiovascular health with all-cause and cardiovascular mortality in adults with and without cancer: a retrospective cohort study.

Article References:
Peng, S., Chen, Q., Liu, Q., et al. Association of the American Heart Association’s new “Life’s Essential 8” cardiovascular health with all-cause and cardiovascular mortality in adults with and without cancer: a retrospective cohort study. BMC Cancer 25, 1706 (2025). https://doi.org/10.1186/s12885-025-14464-7

Image Credits:
Scienmag.com

DOI:
10.1186/s12885-025-14464-7 (Published 04 November 2025)

Keywords:
Cardiovascular health, Life’s Essential 8, all-cause mortality, cardiovascular mortality, cancer survivorship, NHANES, retrospective cohort study, AHA health metrics